IL5 and asthma: Traditional markers of asthma such as FEV1 and the acute bronchodilator response may not be related to the efficacy of anti–IL-5, while existing data suggested the pathogenesis of asthma exacerbation appear to be correlated with eosinophilic inflammation [14]–[16].